Zobrazeno 1 - 10
of 1 366
pro vyhledávání: '"Rustomjee, R"'
Autor:
Rustomjee R, Zumla A
Publikováno v:
Infection and Drug Resistance, Vol 2016, Iss Issue 1, Pp 43-45 (2016)
Rustomjee R, Zumla A. Delamanid expanded access novel treatment of drug resistant tuberculosis. Infection and Drug Resistance. 2015;8:359–366. Dr Rustomjee and Professor Zumla are grateful to a reader for raising some issues regarding referencing,
Externí odkaz:
https://doaj.org/article/fd3dd16e8efb4ba1b44bde8d1aff0107
Autor:
Rustomjee R, Zumla A
Publikováno v:
Infection and Drug Resistance, Vol 2015, Iss default, Pp 359-366 (2015)
Roxana Rustomjee,1 Alimuddin Zumla2,31South African Medical Research Council, Cape Town, South Africa; 2Division of Infection and Immunity, University College London, London, UK; 3NIHR Biomedical Research Centre, University College Hospitals NHS Foun
Externí odkaz:
https://doaj.org/article/745bf430c003431483111209b8f86079
Autor:
Cross RW; Galveston National Laboratory, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America., Longini IM; Department of Biostatistics, University of Florida, Gainesville, Florida, United States of America., Becker S; Institute for Virology, Philipps-Universität Marburg, Marburg, Germany., Bok K; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Boucher D; U.S. COVID-19 Response at U.S. Department of Health and Human Services, Washington, DC, United States of America., Carroll MW; Pandemic Sciences Institute, Nuffield Department of Medicine, Oxford University, United Kingdom., Díaz JV; World Health Organization, Geneva, Switzerland., Dowling WE; Coalition for Epidemic Preparedness Innovations (CEPI), Washington, Washington, DC, United States of America., Draghia-Akli R; Johnson & Johnson-Global Public Health Research and Development, Spring House, Pennsylvania, United States of America., Duworko JT; Partnership for Research on Infectious Diseases in Liberia, Monrovia, Liberia., Dye JM; Virology Division, United States Army Medical Research Institute of Infectious Diseases, Frederick, Maryland, United States of America., Egan MA; Auro Vaccines, Pearl River, New York, United States of America., Fast P; IAVI, New York, New York, United States of America., Finan A; Sabin vaccine Institute, Washington, DC, United States of America., Finch C; Sabin vaccine Institute, Washington, DC, United States of America., Fleming TR; University of Washington, Seattle, Washington, United States of America., Fusco J; Public Health Vaccines, Cambridge, Massachusetts, United States of America., Geisbert TW; Galveston National Laboratory, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America., Griffiths A; National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Maryland, United States of America., Günther S; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany., Hensley LE; Integrated Research Facility, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, Maryland, United States of America., Honko A; National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Maryland, United States of America., Hunegnaw R; Immune Biology of Retroviral Infection Section, Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States of America., Jakubik J; Sabin vaccine Institute, Washington, DC, United States of America., Ledgerwood J; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Luhn K; Janssen Vaccines & Prevention, Leiden, the Netherlands., Matassov D; Auro Vaccines, Pearl River, New York, United States of America., Meshulam J; Auro Vaccines, Pearl River, New York, United States of America., Nelson EV; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany., Parks CL; IAVI, New York, New York, United States of America., Rustomjee R; Sabin vaccine Institute, Washington, DC, United States of America., Safronetz D; Zoonotic Diseases and Special Pathogens Division, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada., Schwartz LM; World Health Organization, Geneva, Switzerland., Smith D; Bacterial and Combination Vaccines, Public Health Agency of Canada, Ottawa, Ontario, Canada., Smock P; Sabin vaccine Institute, Washington, DC, United States of America., Sow Y; Collaborative Clinical Research Branch, Division of Clinical Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, United States of America., Spiropoulou CF; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America., Sullivan NJ; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America., Warfield KL; Emergent BioSolutions, Gaithersburg, Maryland, United States of America., Wolfe D; Bacterial and Combination Vaccines, Public Health Agency of Canada, Ottawa, Ontario, Canada., Woolsey C; Galveston National Laboratory, and Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America., Zahn R; Janssen Vaccines & Prevention, Leiden, the Netherlands., Henao-Restrepo AM; World Health Organization, Geneva, Switzerland., Muñoz-Fontela C; Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany., Marzi A; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, United States of America.
Publikováno v:
PLoS pathogens [PLoS Pathog] 2022 Oct 13; Vol. 18 (10), pp. e1010805. Date of Electronic Publication: 2022 Oct 13 (Print Publication: 2022).
Autor:
Finch CL; Sabin Vaccine Institute, Washington, DC 20037, USA., Dowling WE; Coalition for Epidemic Preparedness Innovations, Washington, DC 20006, USA., King TH; Sabin Vaccine Institute, Washington, DC 20037, USA., Martinez C; Sabin Vaccine Institute, Washington, DC 20037, USA., Nguyen BV; Biomedical Advanced Research and Development Authority, Office of the Assistant Secretary for Preparedness and Response, Department of Health and Human Services, Washington, DC 20201, USA., Roozendaal R; Janssen Vaccines and Prevention B.V., Leiden Archimedesweg 4, 2333 CN Leiden, The Netherlands., Rustomjee R; Sabin Vaccine Institute, Washington, DC 20037, USA., Skiadopoulos MH; Microvirion Vaccine Consulting, Rockville, MD 20852, USA., Vert-Wong E; Sabin Vaccine Institute, Washington, DC 20037, USA., Yellowlees A; Quantics Biostatistics, Edinburgh EH3 8EG, UK., Sullivan NJ; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Publikováno v:
Vaccines [Vaccines (Basel)] 2022 Aug 25; Vol. 10 (9). Date of Electronic Publication: 2022 Aug 25.
Autor:
Finch CL; Sabin Vaccine Institute, Washington, DC 20037, USA., Martinez C; Sabin Vaccine Institute, Washington, DC 20037, USA., Leffel E; Leffel Consulting Group, LLC, Eagle Rock, VA 24058, USA., Skiadopoulos MH; Microvirion Vaccine Consulting, Rockville, MD 20852, USA., Hacker A; Coalition for Epidemic Preparedness Innovations, Bloomsbury, London NW1 2BE, UK., Mwesigwa B; Makerere University Walter Reed Project, Kampala 16524, Uganda., Maïga D; Regional Office of Africa, World Health Organization, Brazzaville P.O. Box 06, Congo., Mugisa I; National Drug Authority, Kampala 23096, Uganda., Munkwase G; National Drug Authority, Kampala 23096, Uganda., Rustomjee R; Sabin Vaccine Institute, Washington, DC 20037, USA.
Publikováno v:
Vaccines [Vaccines (Basel)] 2022 Feb 26; Vol. 10 (3). Date of Electronic Publication: 2022 Feb 26.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Zumla, A., Chakaya, J., Hoelscher,M., Ntoumi, F., Rustomjee, R., Vilaplana, C., Yeboah-Manu, D., Rasolofo, V., Munderi, P., Singh, N., Aklillu, E., Padayatchi, N., Macete, E., Kapata, N., Mulenga, M., Kibiki, G., Mfinanga, S., Nyirenda, T., Maboko, L., Garcia-Basteiro, A., Rakotosamimanana, N., Bates, M., Mwaba, P., Reither, K., Gagneux, S., Edwards, S., Mfinanga, E., Abdulla, S., Cardona, P.J., Russell, J.B.W., Gant, V., Noursadeghi, M., Elkington, P., Bonnet, Maryline
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_______932::ed894ce5042a2d40cb9f6d06ee713b43
http://www.documentation.ird.fr/hor/fdi:010067378
http://www.documentation.ird.fr/hor/fdi:010067378
Autor:
Zumla, A, Maeurer, M, Chakaya, J, Hoelscher, M, Ntoumi, F, Rustomjee, R, Vilaplana, C, Yeboah-Manu, D, Rasolofo, V, Munderi, P, Singh, N, Aklillu, E, Padayatchi, N, Macete, E, Kapata, N, Mulenga, M, Kibiki, G, Mfinanga, S, Nyirenda, T, Mboko, L, Garcia-Basteiro, AL, Rakotosamimanana, N, Bates, M, Mwaba, P, Reither, K, Gagneux, S, Edwards, S, Mfinanga, E, Abdulla, S, Cardona, P-J, Russell, JBW, Gant, V, Noursadeghi, M, Elkington, P, Bonnet, M, Menendez, C, Dieye, TN, Diarra, B, Maiga, A, Aseffa, A, Parida, S, Wejse, C, Petersen, E, Kaleebu, P, Oliver, M, Craig, G, Corrah, T, Tientcheu, L, Antonio, M, McHugh, TD, Sheikh, A, Ippolito, G, Ramjee, G, Kaufmann, SHE, Churchyard, G, Steyn, AJC, Grobusch, MP, Sanne, I, Martinson, N, Mandansein, R, Wilkinson, RJ, Wallis, RS, Mayosi, B, Schito, M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______1032::cd4225445b9ea567aa9c53a9938647b7
http://hdl.handle.net/10044/1/51747
http://hdl.handle.net/10044/1/51747
Autor:
Verboven, Lennert1,2 (AUTHOR) lennert.verboven@uantwerpen.be, Callens, Steven3 (AUTHOR), Black, John4 (AUTHOR), Maartens, Gary5 (AUTHOR), Dooley, Kelly E.6 (AUTHOR), Potgieter, Samantha7 (AUTHOR), Cartuyvels, Ruben8 (AUTHOR), Laukens, Kris2 (AUTHOR), Warren, Robin M.9 (AUTHOR), Van Rie, Annelies1 (AUTHOR)
Publikováno v:
PLoS ONE. 9/6/2024, Vol. 19 Issue 9, p1-18. 18p.